Valuation

Biopharma M&A has fallen off a cliff – but IP owners in the sector have reasons to be cheerful

The number and value of acquisitions have both tumbled further than in the early months of 2020

Biopharma M&A has fallen off a cliff – but IP owners in the sector have reasons to be cheerful
Singapore banking on regional IP rise and dispute resolution to cement its hub status
19 Jul 2021

Singapore banking on regional IP rise and dispute resolution to cement its hub status

An update to the country’s strategy recognises that facilitating ASEAN's patenting development is key

Confidence in Biden’s patent policies tumbles, according to new <em>IAM</em> survey
1 Jul 2021

Confidence in Biden’s patent policies tumbles, according to new IAM survey

Second quarter panels report finds a marked increase in negative views about the administration, but fewer covid concerns and signs of higher royalty and sales prices

Latest

View all
29 Jun 2021

University and Big Pharma JV’s $145 million take-off is a big boost for tech transfer dealmaking

Apollo Therapeutics is an innovative biotech formed by three UK universities and three major companies, with a promising model for creating and monetising life sciences IP Read more

23 Jun 2021

Via Licensing looks to extend its hold on audio space with next-gen patent pool

Company president Joe Siino tells IAM the pool operator has secured virtually all the key innovators behind MPEG-H to roll out a unified licensing solution Read more

17 Jun 2021

In the mobile licensing world, US patent holdings do not have the power they did

Globalisation in the 5G era has reduced the clout of portfolios centred on the country, but decisions taken by the government, the courts and in boardrooms have hastened the process Read more

15 Jun 2021

$2 billion deal shows growing sophistication of drug royalty sales

Latest Royalty Pharma investment shows is further evidence of the increasing IP monetisation options open to healthcare innovators Read more

News

View all
22 Dec 2020

The keys to effective IP monetisation

Patent licensing is as much an art as it is a science, explain some of those featured in the new IAM Strategy 300 Global Leaders guide Read more

19 Nov 2020

Your guide to covid-19 vaccine stakeholders’ IP strategies

IAM examines the approaches taken by – and the issues facing – the leading companies in the race to find effective coronavirus inoculations Read more

9 Nov 2020

Pfizer’s covid vaccine found 90% effective, but raises IP questions

Company CEO proclaims “a great day for science and humanity”, but there are patent, know-how and data uncertainties to overcome Read more

20 Jul 2020

After success of early stage covid-19 vaccine trial, Oxford University's coronavirus IP policy explained

With the promising news today that a coronavirus vaccine being developed by scientists at the university is safe and triggers an immune response, we revisit our exclusive April interview with the head of Oxford's tech transfer office in which he talks about its new, expedited, approach to granting covid-related licences Read more

Analysis

View all
1 Jun 2021

Xiaomi royalty figures show importance of IP strategy as it grows international footprint

In a banner quarter, company gets off US government blacklist, grows profits, and pays a hefty royalty sum Read more

19 May 2021

How to calculate ROI for patent portfolios and boost corporate value

The Long Read: These days, both the tools and data are available to develop models for creating significant value from corporate IP assets. All too often, though, what is still missing is the will to use them. Jeremiah Chan and Jonathan Liu of Facebook and Cipher’s Nigel Swycher and Steve Harris argue that a change of mindset among portfolio managers could reap significant rewards Read more

14 May 2021

Big jury verdicts reflect significant shifts in the US patent landscape, damages experts claim

With litigation funding flooding the market and the appropriate payout for a plaintiff receiving more focus in a trial, the spate of big court awards may be set to continue Read more

12 May 2021

Australian government unveils patent box tax regime as part of upcoming budget

New scheme is aimed at encouraging biotech innovation, and follows years of industry warnings about offshoring of intellectual property Read more

Insights

View all
8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more

1 Oct 2017

A round-up of IP-related quotes, observations and opinions from the recent past …

A round-up of IP-related quotes, observations and opinions from the recent past …

Read more

30 Sep 2016

McRO gives hope to US patent owners, but Section 101 uncertainty remains

After two years of uncertainty and no little gloom, a recent Federal Circuit decision may just herald the long-awaited swing-back in the pendulum that software patent owners in the United States have been waiting for. Some, though, still believe that Congress must bite the bullet and take a look at Section 101 Read more

1 Aug 2016

Brexit leaves the UPC in limbo – and that’s no bad thing

The UK vote to leave the European Union may have surprised and disappointed many in the IP community, but a rush to bypass the decision and implement the unitary patent package would be a mistake

Read more

Find an expert